AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2021
Aug 18, 2021
33298_dirs_2021-08-18_0ce042cb-bdfe-47f6-a938-057f37e809ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2021-08-18
Reporting Person: Benathen Marc David (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-18 | Common Stock | P | 1297 | $7.23 | Acquired | 17953 | Direct |
| 2021-08-18 | Common Stock | P | 1300 | $7.26 | Acquired | 19253 | Direct |
| 2021-08-18 | Common Stock | P | 64 | $7.29 | Acquired | 19317 | Direct |
| 2021-08-18 | Common Stock | P | 63 | $7.24 | Acquired | 19380 | Direct |
| 2021-08-18 | Common Stock | P | 343 | $7.43 | Acquired | 19723 | Direct |
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17